cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cytomx Therapeutics Inc
12 own
11 watching
Current Price
$1.38
$-0.08
(-5.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
91.82M
52-Week High
52-Week High
5.85000
52-Week Low
52-Week Low
1.04000
Average Volume
Average Volume
1.63M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization91.82M
icon52-Week High5.85000
icon52-Week Low1.04000
iconAverage Volume1.63M
iconDividend Yield--
iconP/E Ratio--
What does the Cytomx Therapeutics Inc do?
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company s product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatment of squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma; BMS-986249, a CTLA-4 Probody therapeutic drug, which is in Phase I/II clinical trials for the treatment of metastatic melanoma; and BMS-986288, an anti-CTLA-4 Probody drug, which is in Phase I clinical trials for the treatment of solid tumors. It also develops CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, as well as CX-904, a conditionally activated epidermal growth factor receptor for the treatment of solid tumor. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.
Read More
How much money does Cytomx Therapeutics Inc make?
News & Events about Cytomx Therapeutics Inc.
Globe Newswire
11 months ago
- Financing is expected to extend cash runway into the 2nd half of 2025 based on current operating plans, enabling the Company to reach multiple clinical milestones - - $30 million initial...
Zolmax
1 year ago
CytomX Therapeutics (NASDAQ:CTMX Get Rating) and Stoke Therapeutics (NASDAQ:STOK Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, ...
PR Newswire
1 year ago
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire VANCOUVER, British Columbia, March 24, 2023 FN Media Group Presents USA News Group News Commentary VANCOUVER...
Globe Newswire
1 year ago
-Achievement of clinical candidate is the first in the multi-target collaboration and triggersa $5 million milestone payment to CytomX- -CytomX-retained US co-commercialization and economic rights for select programs- SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics...
PR Newswire
1 year ago
Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire NEW YORK, Jan. 6, 2023 NEW...
Frequently Asked Questions
Frequently Asked Questions
What is Cytomx Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Cytomx Therapeutics Inc shares?
plus_minus_icon
How can I buy Cytomx Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Cytomx Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cytomx Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Cytomx Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Cytomx Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cytomx Therapeutics Inc?
plus_minus_icon
What percentage is Cytomx Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cytomx Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.38
$-0.08
(-5.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00